Evidence supporting the use of: Marijuana
For the health condition: Crohn's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Marijuana (cannabis) has been explored as a supportive therapy for Crohn's Disease due to its anti-inflammatory and immunomodulatory properties primarily mediated through the endocannabinoid system. Some patients report symptomatic relief, especially in terms of pain, appetite, and quality of life. However, the scientific evidence for its efficacy in treating the underlying inflammation of Crohn’s Disease is limited and mixed. A small double-blind, placebo-controlled study published in Clinical Gastroenterology and Hepatology (Naftali et al., 2013) found that inhaled cannabis improved symptoms but did not induce clinical remission. A 2021 review in Alimentary Pharmacology & Therapeutics concluded that while cannabis may improve patient-reported symptoms, it does not appear to reduce inflammation or lead to sustained remission. Most available studies are small, short-term, and have methodological limitations. Guidelines from organizations such as the American Gastroenterological Association do not recommend cannabis as a primary treatment for Crohn's Disease due to insufficient high-quality evidence. Overall, while there is some scientific investigation into cannabis for Crohn’s, current evidence does not strongly support its use for modifying disease activity, but it may help with symptom management in select patients.

More about Marijuana
More about Crohn's Disease

Products containing Marijuana

We currently have no products on Vitabase that contain this ingredient.